Herbalife (HLF) Faces Investigation By Law Firms, Stock Down
Zacks Investment Research | Jun 05, 2017 09:17PM ET
Herbalife Ltd. (NYSE:HLF) shares slumped more than 6% yesterday, when law firms Faruqi & Faruqi, LLP and Lundin Law PC announced investigation against the company related to possible violations of federal securities laws.
We note that the company slashed its sales guidance yesterday, after raising the guidance in May during first-quarter 2017 conference call . In addition, the company's general counsel, Mark Friedman, who was involved in the 2016 settlement with U.S. regulators for deceiving investors, stepped down. This raised questions on the company’s compliance with federal securities laws.
Herbalife now expects sales to decline 2–6%, compared with 0.5–4.5% decline expected earlier. Also, volumes are expected to decrease 4–8% compared with previous range of 1–5% for the second quarter.
The company expects net sales in 2017 to increase nearly 0.5–3.5% versus 3–6% anticipated earlier. Volumes are projected to be down 1% to up 2% compared with previous guided range of 2–5% growth.
Herbalife issued soft sales guidance for both the second quarter and 2017, due to the new Federal Trade Commission rules in the U.S., softness in its Mexico operations and distributors adopting the latest protocols.
Notably, this California-based company has always remained under the scanner. Billionaire investor Bill Ackman made a $1 billion bet against the nutrition company in Dec 2012 and accused it of being a pyramid scheme i.e. it employs deceptive marketing practices for improving business. Ackman believed that the nutrition clubs run by Herbalife's distributors focus on recruitment instead of selling products. Herbalife had received a civil investigative demand in 2014 from the FTC related to its marketing practices. However, Herbalife resolved the probe with the FTC and paid $200 million in fines and settlements without being named a pyramid scheme.
Herbalife has been forced to prove that 80% of its annual sales come from documented consumer purchases. Yesterday, the company outpaced the key threshold of 80% under its agreement with the U.S. Federal Trade Commission. It announced that 90% of the U.S. sales in May were documented purchases, which consisted of over three million receipted retail transactions.
Despite the allegations, Herbalife has remained upbeat about its prospects. Recently, this Zacks Rank #1 (Strong Buy) company posted better-than-expected first-quarter 2017 results. In fact, Herbalife’s earnings have outpaced the Zacks Consensus Estimate for 10 straight quarters now, with a trailing four-quarter average of 18.4%.
Get The News You Want
The company’s shares have outperformed both the Zacks categorized Retail–Drug Stores industry and the broader sector year to date. Meanwhile, the Zacks categorized Retail-Wholesale sector gained 15.6%. This stock surged 43.3% against the industry’s decline of 1.6%. The industry is currently placed at top 15% of the Zacks Classified industries (40 out of 256).
Other Stocks to Consider
Some other top-ranked stocks worth considering in the broader Retail-Wholesale sector include The Children's Place, Inc. (NASDAQ:PLCE) , Best Buy Co., Inc. (NYSE:BBY) and J.Jill, Inc. (NYSE:JILL) .
Children's Place, with a long-term earnings growth rate of 8%, has posted an average earnings beat of 36.6% in the past four quarters. The stock currently sports a Zacks Rank #1 (Strong Buy). You can see .
Best Buy, a Zacks Rank #1 stock has a long-term earnings growth rate of 11.4%. Also, it has posted an average earnings beat of 33.8% in the last four quarters.
J.Jill carries a Zacks Rank #2 (Buy) and has a long-term earnings growth rate of 19.8%.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.